Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients. (Q46490039)

From Wikidata

Jump to navigation Jump to search

scientific article published on 22 May 2014

Language	Label	Description	Also known as
English	Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients.	scientific article published on 22 May 2014

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Blood miRNA expression pattern is a possible risk marker for natalizumab-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

multiple sclerosis

0 references

microRNA expression

0 references

progressive multifocal leukoencephalopathy

0 references

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Adolfo López de Munain

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Tamara Castillo-Triviño

3

object named as

T Castillo-Triviño

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

author name string

M Muñoz-Culla

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

H Irizar

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

M Sáenz-Cuesta

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

L Sepúlveda

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

I Lopetegi

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

J Olascoaga

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

S E Baranzini

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

publication date

22 May 2014

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1851-1859

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Risk of natalizumab-associated progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Revisiting the principles of microRNA target recognition and mode of action

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNAs within the continuum of postgenomics biomarker discovery

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

The potential role of microRNA-146 in Alzheimer's disease: biomarker or therapeutic target?

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

NAViGaTing the micronome--using multiple microRNA prediction databases to identify signalling pathway-associated microRNAs

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Gene enrichment profiles reveal T-cell development, differentiation, and lineage-specific transcription factors including ZBTB25 as a novel NF-AT repressor

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

MicroRNAs may solve the mystery of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Long-term follow-up of peripheral lymphocyte subsets in a cohort of multiple sclerosis patients treated with natalizumab

1 reference

https://api.crossref.org/works/10.1177%2F1352458514534513

21 January 2018

Identifiers

10.1177/1352458514534513

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24852919%20AND%20SRC:MED&resulttype=core&format=json

19 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46490039&oldid=1744811987"